Literature DB >> 26023626

Valproate Induced Delirium due to Hyperammonemia in a Case of Acute Mania: A Diagnostic Dilemma.

Siddharth Dixit1, Mayank Namdeo2, Sudip Azad2.   

Abstract

Divalproex sodium is commonly used drug to treat variety of psychiatric and neurological disorders. Hyperammonemia is infrequent adverse affect of treatment with divalproex sodium. It needs high degree of clinical suspicion or else can lead to delirium of non hepatic origin in some group of patients and to medication errors or even death. We hereby report a case of mania who developed hyperammonemia with normal sodium valproate levels and liver function tests where delirium lead to diagnostic and medication errors. Withdrawal of divalproex sodium led to clinical recovery but delirium prolonged his hospital stay. This case report cautions the clinicians about hyperammonemia as the uncommon side effects and emphasizes the need of doing blood ammonia testing in patients treated with divalproex sodium where recovery is halted or clinical condition worsens despite normal liver function test and EEG.

Entities:  

Keywords:  Bipolar disorder; Encephalopathy; Non hepatic hyperammonemia; Valproic acid

Year:  2015        PMID: 26023626      PMCID: PMC4437142          DOI: 10.7860/JCDR/2015/11830.5758

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  15 in total

1.  Valproate-induced hyperammonaemia.

Authors:  Michele Raja; Antonella Azzoni
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

2.  Valproate-induced hyperammonemic encephalopathy: an update on risk factors, clinical correlates and management.

Authors:  Amit Chopra; Bhanu Prakash Kolla; Meghna P Mansukhani; Pamela Netzel; Mark A Frye
Journal:  Gen Hosp Psychiatry       Date:  2012-02-02       Impact factor: 3.238

Review 3.  Hyperammonemia due to valproic acid in the psychiatric setting.

Authors:  Russell B Carr; Kerrie Shrewsbury
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

4.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

5.  Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.

Authors:  F Barrueto; J B Hack
Journal:  Acad Emerg Med       Date:  2001-10       Impact factor: 3.451

Review 6.  Valproate-induced hyperammonemic encephalopathy.

Authors:  Alberto Verrotti; Daniela Trotta; Guido Morgese; Francesco Chiarelli
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

Review 7.  Carnitine in the treatment of valproic acid-induced toxicity.

Authors:  Philippe E R Lheureux; Philippe Hantson
Journal:  Clin Toxicol (Phila)       Date:  2009-02       Impact factor: 4.467

8.  Hyperammonemia and coma developed by a woman treated with valproic acid for affective disorder.

Authors:  E Eze; M Workman; B Donley
Journal:  Psychiatr Serv       Date:  1998-10       Impact factor: 3.084

9.  Valproate-induced hyperammonemic encephalopathy: A reminder of rare complication of valproate.

Authors:  Mohan Gurjar; Sanjay Singhal; A K Baronia; Afzal Azim; Banani Poddar
Journal:  J Emerg Trauma Shock       Date:  2011-04

10.  Valproic Acid-induced hyperammonemia in the elderly: a review of the literature.

Authors:  Vikrant Mittal; Sunanda Muralee; Rajesh R Tampi
Journal:  Case Rep Med       Date:  2009-08-19
View more
  10 in total

1.  Valproate Induced Hyperammonemic Delirium.

Authors:  Anupama Muraleedharan; Dhanya Sasidharan Palappallil; Reneega Gangadhar; Soumitra Das
Journal:  J Clin Diagn Res       Date:  2015-12-01

2.  The Menacing Side of Valproate: A Case Series of Valproate-induced Hyperammonemia.

Authors:  Deeksha Elwadhi; Rashmi Prakash; Manushree Gupta
Journal:  Indian J Psychol Med       Date:  2017 Sep-Oct

3.  A Case Series of Severe Hyperammonemia Encephalopathy Related to Valproate: Can Antipsychotics Increase the Risk?

Authors:  Effat Davoudi-Monfared; Mojan Radmehr; Padideh Ghaeli; Maryam Mousavi
Journal:  Iran J Psychiatry       Date:  2019-07

4.  Valproic Acid Induced Hyperammonemia in a Long Time Treated Patient.

Authors:  Rohit Aiyer; Margaret Seide; Robert G Stern
Journal:  Case Rep Psychiatry       Date:  2016-07-19

5.  Valproate induced hyperammonemic encephalopathy treated by haemodialysis.

Authors:  Vinay Singh Chauhan; Siddarth Dixit; Sunil Goyal; Sudip Azad
Journal:  Ind Psychiatry J       Date:  2017 Jan-Jun

6.  Valproate-Induced Hyperammonemic Encephalopathy.

Authors:  Faiza Farooq; Javeria Sahib Din; Ali M Khan; Syeda Naqvi; Shanila Shagufta; Abdul Mohit
Journal:  Cureus       Date:  2017-08-22

7.  Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review.

Authors:  Lauren M Brown; Nicole Cupples; Troy A Moore
Journal:  Ment Health Clin       Date:  2018-04-26

8.  Carglumic Acid Treatment of a Patient with Recurrent Valproic Acid-induced Hyperammonemia: A Rare Case Report.

Authors:  Yasar Sattar; Saad Wasiq; Waqas Yasin; Ali M Khan; Mahwish Adnan; Shristi Shrestha; Nirav B Patel; Sharaad Latchana
Journal:  Cureus       Date:  2018-09-12

9.  Noncirrhotic hyperammonemia: A factor behind dementia to alter mental status.

Authors:  Christopher Leo; Yun Wang; Alexander Mold; Junik Quintana; Hong Shi; Mahdi Abdullah; Dariush Alaie; Richard Petrillo
Journal:  Clin Case Rep       Date:  2019-09-27

10.  Hyperammonemia in patients receiving valproic acid in the hospital setting: A retrospective review.

Authors:  Tressa McMorris; Angela Chu; Lynn Vu; Amanda Bernardini
Journal:  Ment Health Clin       Date:  2021-07-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.